Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × Ipilimumab × Clear all

NCT02923934 2024-07-24

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Phase 2 Completed

EndocrineGastrointestinalNET

Gastrointestinal Neoplasms, Neuroendocrine Tumors

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms